This retrospective cohort study examined the safety and efficacy of testosterone replacement therapy (TRT) in hypogonadal men who had undergone radical prostatectomy for prostate cancer. The study included 103 men with a mean age of 62 years, all with low testosterone levels post-surgery. Findings indicated that TRT effectively increased serum
